摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-amino-5-phosphonopentanoic acid | 79055-67-7

中文名称
——
中文别名
——
英文名称
(S)-2-amino-5-phosphonopentanoic acid
英文别名
L(+)-2-Amino-5-phosphonopentanoic acid;(S)-(+)-2-amino-5-phosphonopentanoic acid;(S)-2-amino-4-phosphonovaleric acid;L-2-amino-5-phosphonopentanoic acid;D(2)-2-amino-5-phosphonopentanoate;AP 5;(2S)-2-ammonio-5-phosphonopentanoate;(2S)-2-azaniumyl-5-phosphonopentanoate
(S)-2-amino-5-phosphonopentanoic acid化学式
CAS
79055-67-7
化学式
C5H12NO5P
mdl
——
分子量
197.128
InChiKey
VOROEQBFPPIACJ-BYPYZUCNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    105°C
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    -5.3
  • 重原子数:
    12
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    121
  • 氢给体数:
    4
  • 氢受体数:
    6

安全信息

  • 危险品标志:
    Xi
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3
  • 安全说明:
    S26,S36

SDS

SDS:a648e0fdcabfd59ba677bec5c0e8a29f
查看
Name: L(+)-2-Amino-5-phosphonovaleric acid 95% (>99% e.e.) 0.25 mole EtOH Material Safety Data Sheet
Synonym: L-5-Phosphononorvaline; L-2-Amino-5-phosphonopentanoic acid; L-AP-5; 5-Phosphono-L-norvaline; L-2-Amino-5-phosphonopentanoic acid; L-2-Amino-5-phosphonovaleric acid
CAS: 79055-67-7
Section 1 - Chemical Product MSDS Name:L(+)-2-Amino-5-phosphonovaleric acid 95% (>99% e.e.) 0.25 mole EtOH Material Safety Data Sheet
Synonym:L-5-Phosphononorvaline; L-2-Amino-5-phosphonopentanoic acid; L-AP-5; 5-Phosphono-L-norvaline; L-2-Amino-5-phosphonopentanoic acid; L-2-Amino-5-phosphonovaleric acid

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
79055-67-7 L-(+)-2-Amino-5-phosphonovaleric acid 95 unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract.
Inhalation:
May cause respiratory tract irritation.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove contaminated clothing and shoes. Get medical aid if irritation develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Combustion generates toxic fumes. Use water spray to keep fire-exposed containers cool.
Extinguishing Media:
Use water spray, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Avoid breathing dust.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 79055-67-7: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white
Odor: No data
pH: Not available.
Vapor Pressure: Negligible
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 100 - 110 deg C
Autoignition Temperature: Not available.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H12NO5P
Molecular Weight: 197.13

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Strong oxidizers.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, oxides of phosphorus, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 79055-67-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
L-(+)-2-Amino-5-phosphonovaleric acid - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 79055-67-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 79055-67-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 79055-67-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    通过修饰的Seebach咪唑烷二酮类化合物高度对映选择性合成(R)-和(S)-2-氨基-5-膦基戊酸[(R)-和(S)-AP5]
    摘要:
    描述了四种新的立体异构体1-羰基苄氧基-2-叔丁基-3-(α-甲基苄基)-1,3-咪唑啉丁-4-酮的制备。这些手性甘氨酸衍生物的烯醇锂的烷基化以高非对映选择性进行。特别地,不同异构体(2 R,1 'S)-和(2 S,1'R)-7的反应,提供了具有≥98%非对映选择性的所需磷酸化产物9。烷基化产物的水解在相对温和的条件下进行,得到对映体纯的α-取代的α-氨基酸。因此,(2R,5R,1'S)-9和(2S,5S,1'R)-9的水解提供了生理上重要的对映体纯的氨基膦酸(R)-AP5和(S)-AP5。
    DOI:
    10.1016/0040-4020(95)00091-l
  • 作为产物:
    描述:
    (2S,5S,1'R)-1-carbobenzyloxy-2-tert-butyl-3-(α-methylbenzyl)-5-(diethyl 3-propylphosphonate)-1,3-imidazolidin-4-one 在 盐酸methyloxirane 作用下, 生成 (S)-2-amino-5-phosphonopentanoic acid
    参考文献:
    名称:
    通过修饰的Seebach咪唑烷二酮类化合物高度对映选择性合成(R)-和(S)-2-氨基-5-膦基戊酸[(R)-和(S)-AP5]
    摘要:
    描述了四种新的立体异构体1-羰基苄氧基-2-叔丁基-3-(α-甲基苄基)-1,3-咪唑啉丁-4-酮的制备。这些手性甘氨酸衍生物的烯醇锂的烷基化以高非对映选择性进行。特别地,不同异构体(2 R,1 'S)-和(2 S,1'R)-7的反应,提供了具有≥98%非对映选择性的所需磷酸化产物9。烷基化产物的水解在相对温和的条件下进行,得到对映体纯的α-取代的α-氨基酸。因此,(2R,5R,1'S)-9和(2S,5S,1'R)-9的水解提供了生理上重要的对映体纯的氨基膦酸(R)-AP5和(S)-AP5。
    DOI:
    10.1016/0040-4020(95)00091-l
点击查看最新优质反应信息

文献信息

  • Soloshonok, Vadim A.; Belokon, Yuri N.; Kuzmina, Nadezhda A., Journal of the Chemical Society. Perkin transactions I, 1992, # 12, p. 1525 - 1530
    作者:Soloshonok, Vadim A.、Belokon, Yuri N.、Kuzmina, Nadezhda A.、Maleev, Victor I.、Svistunova, Nataly Yu.、et al.
    DOI:——
    日期:——
  • Asymmetric synthesis of heteroorganic analogs of natural products. 6. (S)-?-amino-?-phosphonocarboxylic acids
    作者:V. A. Soloshonok、N. Yu. Svistunova、V. P. Kukhar'、V. A. Solodenko、N. A. Kuz'mina、A. B. Rozhenko、S. V. Galushko、I. P. Shishkina、A. O. Gudima、Yu. N. Belokon'
    DOI:10.1007/bf00869521
    日期:1992.2
    Alkylation, by omega-haloalkylphosphonates, of the Ni(II) complex of the Schiff base formed from glycine and (S)-2-N-(N1-benzylprolyl)-o-aminobenzophenone has been used for the asymmetric synthesis of (S)-2-amino-4-phosphonobutyric and (S)-2-amino-5-phosphonovaleric acids.
  • EUERBY, MELVIN R.;PARTRIDGE, LYNDA Z.;NUNN, PETER B., J. CHROMATOGR., 469,(1989) C. 412-419
    作者:EUERBY, MELVIN R.、PARTRIDGE, LYNDA Z.、NUNN, PETER B.
    DOI:——
    日期:——
  • NATCHEV, I., IZV. XIM. BLG. AN, 22,(1989) N, S. 30-32
    作者:NATCHEV, I.
    DOI:——
    日期:——
  • Highly enantioselective synthesis of (R)- and (S)-2-amino-5-phosphonopentanoic acids [(R)- and (S)-AP5] via modified Seebach imidazolidinones
    作者:Oscar García-Barradas、Eusebio Juaristi
    DOI:10.1016/0040-4020(95)00091-l
    日期:1995.3
    isomers, (2R, 1′S)- and (2S, 1′R)-7, afforded the desired phosphorylated products 9 with ≥ 98% diastereoselectivity. Hydrolysis of the alkylated products proceeds under relatively mild conditions to give enantiomerically pure α-substituted α-amino acids. Thus, hydrolysis of (2R,5R,1′S)-9 and (2S,5S,1′R)-9 provided the physiologically important, enantiopure amino phosphonic acids (R)-AP5 and (S)-AP5.
    描述了四种新的立体异构体1-羰基苄氧基-2-叔丁基-3-(α-甲基苄基)-1,3-咪唑啉丁-4-酮的制备。这些手性甘氨酸衍生物的烯醇锂的烷基化以高非对映选择性进行。特别地,不同异构体(2 R,1 'S)-和(2 S,1'R)-7的反应,提供了具有≥98%非对映选择性的所需磷酸化产物9。烷基化产物的水解在相对温和的条件下进行,得到对映体纯的α-取代的α-氨基酸。因此,(2R,5R,1'S)-9和(2S,5S,1'R)-9的水解提供了生理上重要的对映体纯的氨基膦酸(R)-AP5和(S)-AP5。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物